I added a Hire Me page to the site. Not that I expect a big audience from this blog, but it's mostly so I can have something to link to on social media without linking directly to my resume or LinkedIn. That said, if any of my tech industry readers want to check it out, please do.
Biobot’s national wastewater network shows that COVID-19, influenza A & B, and RSV are holding steady at very low levels in week 23 (through June 7, 2025). National hospitalizations for COVID-19 and RSV also continue to hold steady at low levels, currently at 0.9 and 0.1 per 100,000 people in week 22 (through May 31, 2025). Flu hospitalizations rates have not been updated on the CDC website since May 3rd.
The Bottom Line: All major respiratory viruses are pretty low right now. Enjoy the respite! We’ll continue to keep an eye on things.
National Outlook
COVID-19
National SARS-CoV-2 concentrations are holding steady at very low levels.
Influenza
National flu A & B concentrations are holding steady at very low levels.
RSV
National RSV concentrations are holding steady at very low levels.
Regional
The South
COVID-19: SARS-CoV-2 concentrations are holding steady at low levels in the South.
Influenza: Influenza A concentrations are holding steady at very low levels in the South, while influenza B is slightly increasing.
RSV: RSV concentrations are holding steady at very low levels in the South.
The Midwest
COVID-19: SARS-CoV-2 concentrations are decreasing in the Midwest.
Influenza: Influenza A & B concentrations are holding steady at very low levels in the Midwest.
RSV: RSV concentrations are holding steady at very low levels in the Midwest
The Northeast
COVID-19: SARS-CoV-2 concentrations are holding steady at low levels in the Northeast.
Influenza: Influenza A & B concentrations are holding steady at very low levels in the Northeast.
RSV: RSV concentrations are holding steady at very low levels in the Northeast.
The West
COVID-19: SARS-CoV-2 concentrations are holding steady at low levels in the West.
Influenza: Influenza A & B concentrations are holding steady at very low levels in the West.
RSV: RSV concentrations slightly increased in the West, but remain at very low levels.
Footnotes:
We continue to monitor the evolving H5N1 influenza virus situation, and can now test samples specifically for H5 (including H5N1) — see our blog here and please reach out to hello@biobot.io if interested. A quick reminder that Biobot’s influenza A assay described in this report includes the H5N1 influenza subtype, which is an influenza A virus, but does not distinguish between the different subtypes of influenza A (e.g. H5N1 vs H1N1). We will share any important updates as we have them via Bluesky and in the risk reports.
Wastewater data from Biobot Analytics for RSV, influenza, and SARS-CoV-2 are through June 7, 2025 (MMWR week 23). Clinical data for RSV, influenza, and COVID-19 are from the Centers for Disease Control and Prevention. Updates to clinical data are through May 31, 2025 (MMWR week 22).
I had to cheat to finish Legacy Of Rust. How the hell am I supposed to manage ten Cyberdemons in a tiny arena?! Three different times?! iddqd baby. I don’t care. I finished it. It was a dumb ending.
Which isn’t to say it was a bad episode. The level design up until the final couple levels was really great and fun. But then it just kinda fell apart into monsterslop
June 11th, 2025: You can read more about this paradox here, and can learn more about the trials and tribulations of Sonic The Hedgehog at your local Sega Genesis home video game console!
I've added a light theme to the blog's CSS which should be automatically selected if your system is set to use light mode. The original dark theme will be selected if your system is set to use dark mode.
This is something that improves accessibility, but there's also a practical reason: I myself use light mode. Like many folks with astigmatism, I find dark mode more difficult to read. The effect is worse with high contrast. I initially went with a darker color scheme for the site because I was going for a specific aesthetic, but chose a low contrast set of colors to minimize the impact. That was okay for a while, but I realized that I want a blog I can actually read even when my eyes get tired. And if it bothers me, there are almost certainly other people it bothers as well.
The new theme uses a paper-inspired color scheme to match the logo and overall site design. It's the sort of color scheme that I've started using in a lot of my text editors as well; I find it incredibly comfortable to read. The links are a dark red: an homage to my favorite color of fountain pen ink. I'm really pleased with how it came out.
Hello! Editor Matt here; this is Dracula Weekly, Week 6. A quiet week this week… but it’s about to get quieter.
RECAP
On June 5 we heard a brief note from Dr. Seward, updating us on his star patient. Mr. Renfield has been collecting flies, and this seems to be part of some secret scheme of his. Jack asked him to clean up.
There follows a brief pause while I finish drawing SAVAGE SWORD OF SUSAN, which runs for 11 weeks rather than the usual seven. Yes, it is epic in scale (for a single issue), you guessed right. It’s certainly not 34 pages of titting about in a forest*. I’ll see you back here on the 20th for the unveiling of the cover, and new pages begin to run on June 23rd. My Patreon subscribers will be able to read it in full then.
June 9th, 2025: TCAF was this weekend and it was, as always, a great time. Thank you to everyone who came by to say hi, and I hope we can do it again soon! I also hope you grabbed a lot of rad comics, I KNOW I DID!!
Biobot’s national wastewater network shows that COVID-19, influenza A & B, and RSV are holding steady at very low levels in week 22 (through May 31, 2025). National hospitalizations for COVID-19 and RSV continue to decline, currently at 0.8 and 0.1 per 100,000 people in week 21 (through May 24, 2025). Flu hospitalizations rates have not been updated on the CDC website since May 3rd.
The Bottom Line: All major respiratory viruses are pretty low right now. Enjoy the respite! We’ll continue to keep an eye on things.
National Outlook
COVID-19
National SARS-CoV-2 concentrations are holding steady at very low levels.
Influenza
National flu A & B concentrations are holding steady at very low levels.
RSV
National RSV concentrations are holding steady at very low levels.
Regional
The South
COVID-19: SARS-CoV-2 concentrations are holding steady at low levels in the South.
Influenza: Influenza A & B concentrations in the South are holding steady at very low levels.
RSV: RSV concentrations are holding steady at very low levels in the South.
The Midwest
COVID-19: SARS-CoV-2 concentrations are decreasing in the Midwest.
Influenza: Influenza A & B concentrations are holding steady at very low levels in the Midwest.
RSV: RSV concentrations are holding steady at very low levels in the Midwest
The Northeast
COVID-19: SARS-CoV-2 concentrations are holding steady at low levels in the Northeast.
Influenza: Influenza A & B concentrations are holding steady at very low levels in the Northeast.
RSV: RSV concentrations are holding steady at very low levels in the Northeast.
The West
COVID-19: SARS-CoV-2 concentrations are holding steady at low levels in the West.
Influenza: Influenza A & B concentrations are holding steady at very low levels in the West.
RSV: RSV concentrations are holding steady at very low levels in the West.
Footnotes:
We continue to monitor the evolving H5N1 influenza virus situation, and can now test samples specifically for H5 (including H5N1) — see our blog here and please reach out to hello@biobot.io if interested. A quick reminder that Biobot’s influenza A assay described in this report includes the H5N1 influenza subtype, which is an influenza A virus, but does not distinguish between the different subtypes of influenza A (e.g. H5N1 vs H1N1). We will share any important updates as we have them via Bluesky and in the risk reports.
Wastewater data from Biobot Analytics for RSV, influenza, and SARS-CoV-2 are through May 31, 2025 (MMWR week 22). Clinical data for RSV, influenza, and COVID-19 are from the Centers for Disease Control and Prevention. Updates to clinical data are through May 24, 2025 (MMWR week 21).
June 6th, 2025: Hume didn't use a chicken who is also a detective in his published examples that WE have records of, but in Dinosaur Land, Dinosaur Hume was a little more ambitious. THIS I CLAIM.
TCAF is this weekend! Hopefully I will see you there?? I'm doing a signing at the Penguin Random House booth at 3pm on Saturday June 7th! That's at tables 165-168, located on Home Ice, in the Ice Rink! Yes, this IS the most Canadian place for a comics festival ever in time.
Let me begin by saying: fuck Nintendo. Their insistence on ruining the lives
of people who do anything they disapprove of with the products they sell,
regardless of whether that thing is illegal let alone harmful to them, is
despicable. It creates a chilling effect on vital efforts towards digital
preservation that extends far beyond their own products, on top of just being
a heinous thing to do to fans of their games. The regard in which they
consistently hold their back catalog as assets on which they could one day
collect rent speaks to a deep-rooted capitalistic mindset among the
businessmen who run the company that is in no way outweighed by the positive
things written below.
All that said...
Welcome Tour evinces an attitude somewhere in the company—somewhere
widespread enough to get this game made and translated—that I find deeply
admirable. Unlike the obvious touchpoint ASTRO's Playroom, this is a
tour of the Switch 2 in the most thorough possible sense. It takes the player
not just through the most charismatic features like HD Rumble 2 or the mouse
control scheme, it shows off every square centimeter of the system in a very
literal sense. Players walk across circuit boards and computer chips and learn
about exactly what they do. Every meticulous design decision is laid out for
the player to see.
The result is a game that's intimately concerned
with the physical and design structure of the device it's describing, and that
invites the player to share in that concern. It trusts the player to care
about the craftsmanship with which the console was created, and it provides
tech demos to guide them towards understanding it by directly demonstrating
technical concepts like framerate, HDR, and VRR.
And, yes, this is
in service of convincing buyers that the $450 or whatever they laid out for
this device was worth it by framing it as a meticulously designed luxury
product. But it's also taking a stand and saying that thoughtful, humanistic
design is what defines quality. In an era when every corporate product is
racing to become the worst version of itself that might still be salable, when
overhyped prediction engines that can only produce statistically-average slop
are hailed as the future of content, this is a dramatically heterodox position
for Nintendo to stake out so stridently. I'm impressed and honestly heartened
by it—not enough to look past the company's myriad acts of destruction, but
enough to say that I'm very glad that Welcome Tour is the way it is.